EXHIBIT A
AGREEMENT
Pursuant toRule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Millendo Therapeutics, Inc.
Date: April 7, 2020 | FRAZIER HEALTHCARE VI, L.P. By FHM VI, L.P., its general partner By FHM VI, L.L.C., its general partner | |||||
By: | /s/ Steve R. Bailey | |||||
Steve R. Bailey, Chief Financial Officer |
Date: April 7, 2020 | FHM VI, L.P. By FHM VI, L.L.C., its general partner | |||||
By: | /s/ Steve R. Bailey | |||||
Steve R. Bailey, Chief Financial Officer |
Date: April 7, 2020 | FHM VI, L.L.C. | |||||
By: | /s/ Steve R. Bailey | |||||
Steve R. Bailey, Chief Financial Officer |
Date: April 7, 2020 | By: | * | ||||
James Topper |
Date: April 7, 2020 | By: | * | ||||
Patrick Heron |
Date: April 7, 2020 | By: | * | ||||
Nader Naini |
Date: April 7, 2020 | By: | * | ||||
Nathan Every |
Date: April 7, 2020 | By: | * | ||||
Alan Frazier |
Date: April 7, 2020 | *By: | /s/ Steve R. Bailey | ||||
Steve R. Bailey, as Attorney-in-Fact |
This Agreement was executed by Steve R. Bailey on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on December 17, 2018.